Medicare to restrict coverage of TENS for back pain to clinical trials
This article was originally published in Clinica
Executive Summary
The US Centers for Medicare and Medicaid Services (CMS) is planning to restrict the coverage of transcutaneous electrical nerve stimulation (TENS) devices for chronic lower back pain; the devices will now only be reimbursed for use in placebo-controlled trials.